SSB
MRNA icon

Sandy Spring Bank’s Moderna MRNA Stock Holding History

Sandy Spring Bank’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$27.7K Sell
977
-399
-29% -$14.2K ﹤0.01% 677
2024
Q4 		$57.2K Sell
1,376
-77
-5% -$3.68K ﹤0.01% 552
2024
Q3 		$97.1K Sell
1,453
-158
-10% -$14.5K ﹤0.01% 465
2024
Q2 		$191K Hold
1,611
– – 0.01% 369
2024
Q1 		$172K Sell
1,611
-470
-23% -$47.4K 0.01% 388
2023
Q4 		$207K Sell
2,081
-275
-12% -$23.1K 0.01% 357
2023
Q3 		$243K Buy
2,356
+400
+20% +$44.6K 0.01% 325
2023
Q2 		$238K Sell
1,956
-4
-0.2% -$534 0.01% 333
2023
Q1 		$301K Buy
1,960
+150
+8% +$24.7K 0.02% 303
2022
Q4 		$325K Hold
1,810
– – 0.02% 289
2022
Q3 		$214K Sell
1,810
-25
-1% -$3.79K 0.01% 322
2022
Q2 		$262K Sell
1,835
-30
-2% -$4.29K 0.02% 304
2022
Q1 		$321K Sell
1,865
-65
-3% -$10.9K 0.02% 292
2021
Q4 		$490K Buy
1,930
+673
+54% +$197K 0.02% 261
2021
Q3 		$484K Buy
1,257
+20
+2% +$7.38K 0.03% 261
2021
Q2 		$291K Buy
1,237
+250
+25% +$44.7K 0.02% 300
2021
Q1 		$129K Buy
987
+544
+123% +$78.8K 0.01% 367
2020
Q4 		$47K Buy
443
+193
+77% +$19.5K ﹤0.01% 494
2020
Q3 		$18K Buy
250
+200
+400% +$13.9K ﹤0.01% 608
2020
Q2 		$3K Sell
50
-50
-50% -$2.74K ﹤0.01% 803
2020
Q1 		$3K Buy
+100
New +$2.3K ﹤0.01% 803

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Sandy Spring Bank's MRNA Position: Q1 2025 in Review

Sandy Spring Bank reduced its Moderna (MRNA) stake by 29% in Q1 2025, selling an estimated $14.2K and leaving 977 shares worth $27.7K. The position accounts for ﹤0.01% of the portfolio, ranked #677.

Sandy Spring Bank first reported a position in MRNA in Q1 2020 and has held it in 21 quarters since. The position peaked at $490K in Q4 2021. 694 funds tracked by Wall St. Rank hold MRNA as of Q1 2025.

  • Sandy Spring Bank held 977 shares of Moderna worth $27.7K as of Q1 2025.
  • Sandy Spring Bank sold 399 Moderna shares in Q1 2025, an estimated $14.2K.
  • Moderna made up ﹤0.01% of Sandy Spring Bank's portfolio in Q1 2025, its #677 holding.
  • Sandy Spring Bank first reported a position in Moderna in Q1 2020 and has held it in 21 quarters since.
  • Sandy Spring Bank's Moderna position peaked at $490K in Q4 2021.
  • 694 funds tracked by Wall St. Rank held Moderna as of Q1 2025.

Based on Sandy Spring Bank's 13F filing for Q1 2025, filed 12 May 2025.